These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9646009)

  • 1. Clinical pharmacokinetics of neuromuscular relaxants in pregnancy.
    Guay J; Grenier Y; Varin F
    Clin Pharmacokinet; 1998 Jun; 34(6):483. PubMed ID: 9646009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of muscle relaxants in patients with burns.
    Martyn J; Goldhill DR; Goudsouzian NG
    J Clin Pharmacol; 1986; 26(8):680-5. PubMed ID: 2947935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine.
    Mehta MP; Sokoll MD; Gergis SD
    Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, placental transfer, and neonatal effects of vecuronium and pancuronium administered during cesarean section.
    Dailey PA; Fisher DM; Shnider SM; Baysinger CL; Shinohara Y; Miller RD; Abboud TK; Kim KC
    Anesthesiology; 1984 Jun; 60(6):569-74. PubMed ID: 6145374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions and interactions of the neuromuscular blocking drugs.
    Ostergaard D; Engbaek J; Viby-Mogensen J
    Med Toxicol Adverse Drug Exp; 1989; 4(5):351-68. PubMed ID: 2682131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting neuromuscular-blocking drugs for elderly patients.
    Cope TM; Hunter JM
    Drugs Aging; 2003; 20(2):125-40. PubMed ID: 12534313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waiting time after non-depolarizing relaxants alter muscle fasciculation response to succinylcholine.
    Pinchak AC; Smith CE; Shepard LS; Patterson L
    Can J Anaesth; 1994 Mar; 41(3):206-12. PubMed ID: 7910525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rocuronium is the best non-depolarizing relaxant to prevent succinylcholine fasciculations and myalgia.
    Martin R; Carrier J; Pirlet M; Claprood Y; Tétrault JP
    Can J Anaesth; 1998 Jun; 45(6):521-5. PubMed ID: 9669004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine potentiates nondepolarizing neuromuscular relaxants in a primate.
    Tsai SK; Lee C
    Anesth Analg; 1989 Jan; 68(1):5-8. PubMed ID: 2562910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia.
    Foldes FF; Nagashima H; Boros M; Tassonyi E; Fitzal S; Agoston S
    Br J Anaesth; 1983; 55 Suppl 1():97S-103S. PubMed ID: 6190489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of muscle relaxants for rapid-sequence induction of anaesthesia].
    Hofmockel R; Geldner G; Diefenbach C; Fuchs-Buder T; Ulm K; Blobner M
    Anaesthesist; 2003 Jun; 52(6):516-21. PubMed ID: 12835873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New muscle relaxants in outpatient anesthesiology.
    Goldberg M; Rosenberg H
    Dent Clin North Am; 1987 Jan; 31(1):117-29. PubMed ID: 3542610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of neuromuscular blocking agents.
    Fisher DM
    Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison study of vecuronium bromide and atracurium besylate for rapid sequence induction.
    Davison KL; Holland MS
    AANA J; 1989 Feb; 57(1):37-40. PubMed ID: 2564715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of defasciculating doses of pancuronium and atracurium on succinylcholine neuromuscular blockade.
    Motamed C; Philippe D
    Anesth Pain Med; 2014 Oct; 4(4):e18488. PubMed ID: 25337472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Acid-Base Balance on Anesthetic Muscle Relaxants: A Comprehensive Review on Clinical Applications and Mechanisms.
    Radkowski P; Szewczyk M; Czajka A; Samiec M; Braczkowska-Skibińska M
    Med Sci Monit; 2024 Jul; 30():e944510. PubMed ID: 38949163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative characteristics of atracurium and vecuronium. A simultaneous clinical and pharmacokinetic study.
    Wright PM; Hart P; Lau M; Sharma ML; Gruenke L; Fisher DM
    Anesthesiology; 1994 Jul; 81(1):59-68; discussion 27A. PubMed ID: 7913801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular blockade in the emergency department.
    Batlan DE; Zaid GJ; Johnston WC
    J Emerg Med; 1987; 5(3):225-32. PubMed ID: 3323298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants.
    Fisher DM; Rosen JI
    Anesthesiology; 1986 Sep; 65(3):286-91. PubMed ID: 2875680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.